AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medinice S.A.

Regulatory Filings • Feb 24, 2025

5706_rns_2025-02-24_f08104d5-030c-483b-beb9-4a5a14203b0a.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

Report Content The Management Board of MEDINICE S.A., based in Warsaw (the "Company"),announces that after meeting all the requirements set forth by theregulations in force within the European Union, the Company has receivednotification from the notified body TV Nord Polska regarding thesuccessful completion of the CE MDR comparison certification process forthe PacePress medical device, known as "PacePress Fast."

In the opinion of the Management Board of Medinice, obtaining CE MDRCertification represents a significant milestone in the implementationof the Company's strategy. Securing certification in one of the keymarkets, the European Union, may have a positive impact on the Company'sfinancial performance. The CE certification facilitates the submissionof the product to national regulators in non-EU countries such as theUnited Kingdom, Canada, Switzerland, India or Australia.